Chemotherapy compliance in elderly patients with solid tumors: a real-world clinical practice data

Barbara Radecka, Justyna Czech, Agnieszka Siedlaczek, Marcin Maczkiewicz, Agnieszka Jagiełło-Gruszfeld, Renata Duchnowska

Vol 19, No 4 (2023)

Research paper

Role of TROP 2 overexpression in selected solid tumors

Agnieszka Chmielewska, Tomasz Kubiatowski

Vol 19, No 6 (2023)

Review paper

Optimizing treatment strategies for a MET exon 14 skipping mutation in non-small-cell lung cancer: a case report of sequential immunotherapy and targeted therapy and literature review

Maria Grodkiewicz, Pawel Kozieł, Izabela Chmielewska, Anna Grenda, Paweł Krawczyk, Janusz Milanowski

Vol 19, No 6 (2023)

Case report

Atezolizumab in the treatment of patients with breast cancer

Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Michał Kunkiel, Wojciech Olszewski

Vol 19, No 4 (2023)

Review paper

Pancreatic adenocarcinoma — current trends in diagnosis and treatment

Anna Gruszczyńska, Krzysztof Kowalik, Katarzyna Hetman, Andrzej Modrzejewski

Vol 19, No 4 (2023)

Review paper

Nivolumab in the treatment of thoracic cancer — new possibilities

Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk

Vol 19, No 4 (2023)

Review paper

Recent advances in the treatment of triple-negative breast cancer

Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Michał Kunkiel, Anna Niwińska, Zbigniew Nowecki

Vol 19, No 6 (2023)

Review paper

Expert opinion on adjuvant treatment with osimertinib in patients with non-small cell lung carcinoma after radical tumor resection

Renata Langfort, Maciej Krzakowski, Dariusz M. Kowalski, Rafał Krenke, Tadeusz Orłowski, Witold Rzyman, Bartosz Wasąg

Vol 19, No 4 (2023)

Guidelines / Expert consensus

Niraparib maintenance in newly diagnosed advanced ovarian cancer — review and case series

Martyna Tyszka, Rafał Stec

Vol 19, No 6 (2023)

Review paper

Fertility preservation during oncological treatment

Joanna Kufel-Grabowska, Krzysztof Łukaszuk, Magdalena Błażek, Agnieszka Jagiełło-Gruszfeld, Anna Horbaczewska, Ninela Irga-Jaworska, Robert Jach, Piotr Jędrzejczak, Izabela Kopeć, Maryna Krawczuk-Rybak, Maciej Krzakowski, Katarzyna Pogoda, Maria Sąsiadek, Robert Spaczyński, Monika Urbaniak, Elżbieta Wojciechowska-Lampka, Sławomir Wołczyński, Jacek Jassem

Vol 20, No 2 (2024)

Guidelines / Expert consensus

Is the biology of breast cancer different in patients ≥ 80 years old?

Joanna Hudała-Klecha, Patryk Zając, Agnieszka Siedlaczek, Barbara Radecka

Vol 19, No 4 (2023)

Research paper

Survival of pancreatic cancer patients treated with nab-paclitaxel (nab-P) in clinical practice: analysis of National Health Fund data

Ireneusz Raczyński, Barbara Radecka, Maciej Krzakowski

Vol 19, No 6 (2023)

Research paper

Use of next-generation sequencing in daily routine practice

Adam Płużański, Andrzej Tysarowski, Maciej Kawecki, Jakub Kucharz, Kinga Winiarczyk, Maciej Krzakowski

Vol 19, No 6 (2023)

Review paper

Potassium imbalances induced by systemic cancer therapy: pathophysiology and potential therapeutic strategies

Datis Kalali

Vol 20, No 1 (2024)

Review paper

Clear cell sarcoma from diagnosis and multidisciplinary treatment to clinical trials

Anna M. Czarnecka, Paulina Chmiel, Paweł Sobczuk, Mateusz Spałek, Anna Szumera-Ciećkiewicz, Ewa Bartnik, Marcin Zdzienicki, Tomasz Świtaj, Monika Dudzisz-Śledź, Piotr Rutkowski

Online first

Review paper

Pan-TRK immunohistochemistry as a tool in the screening for NTRK gene fusions in cancer patients

Monika Durzyńska, Irmina M. Michałek

Vol 20, No 1 (2024)

Review paper

Serous cystadenocarcinoma of the pancreas with synchronous breast cancer

Martyna Ziemińska, Aldona Ząber, Andrzej Mazurek, Bartłomiej Grala, Renata Duchnowska

Vol 19, No 6 (2023)

Clinical vignette

Evaluation of the Timed Up and Go test for screening vulnerability and frailty in older cancer patients

Teodoro J. Oscanoa, Edwin Cieza-Macedo, Xavier Vidal, Roman Romero-Ortuno

Vol 20, No 1 (2024)

Research paper

Metachronous breast cancer in a BRCA1 mutation carrier

Karolina Pięta, Izabela Rudy, Maksymilian Kruczała

Vol 19, No 6 (2023)

Case report

Home-based treatment with subcutaneous trastuzumab: safe and acceptable not only during a pandemic — final analysis of the RWD project ‘FlexCare’

Barbara Radecka, Joanna Hudała-Klecha, Dariusz Sawka, Jolanta Sarga, Bożena Noworolska, Grażyna Susczyk, Jolanta Sawicka, Elżbieta Duda, Natalia Obruśnik, Patryk Zając

Vol 20, No 2 (2024)

Research paper

Ripretinib in the treatment of patients with advanced gastrointestinal stromal tumors (GIST)

Emilia Babula, Aleksandra Sikora, Paweł Sobczuk, Piotr Rutkowski

Vol 20, No 1 (2024)

Review paper

Commentary to Recent advances in the treatment of triple-negative breast cancer

Maciej Krzakowski

Vol 19, No 6 (2023)

Commentary

Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer — clinical trials and real-world data

Magdalena Knetki-Wróblewska, Dariusz M. Kowalski

Vol 20, No 3 (2024)

Review paper

Malignant peripheral nerve sheath tumor — from genetics to multidisciplinary treatment

Anna M. Czarnecka, Paulina Chmiel, Paweł Sobczuk, Ewa Bartnik, Mateusz Spałek, Anna Szumera-Ciećkiewicz, Marcin Zdzienicki, Sławomir Falkowski, Piotr Rutkowski

Online first

Review paper

Trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer treatment

Patryk S. Michel, Marek Jankowski, Dawid Sigorski, Tomasz Kubiatowski

Online first

Review paper